RIPK1 and myeloid sarcoma: However, receptor-interacting protein kinase 1 (RIPK1) may be cause a neuroinflammation mechanism and may be related to MS pathogenesis since it mediates cell death and inflammatory signalling and was found to be increased during recorded results18.